Group/causes of death Mortality (%) at 1 year Mortality (%) at 3 years

Slides:

Advertisements

Similar presentations

The MADIT II Trial Multicenter Autonomic Defibrillator Implantation Trial II Presented at the American College of Cardiology 51st Annual Scientific Session.

Advertisements

MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.

K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.

Timing of Intervention in Patients with Acute Coronary Syndromes (TIMACS) AHA, 2008.

A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.

BWGIC survey Victor Legrand Yves Taeymans. PCI 2004 : procedures n=

1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.

Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.

1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.

Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.

Safety of Cyclooxygenase-2 (COX-2) inhibitors, Valdecoxib and Parecoxib, versus Placebo for Post CABG Pain Management Presented at American College of.

Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial Presented at American Heart Association Scientific Sessions 2004 Presented.

Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.

Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.

Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.

TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)

Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme IMAGINEIMAGINE Presented at The European Society of.

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Limitations of Ejection Fraction for Prediction.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.

Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at The American College.

Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.

From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:

Figure 9.1 Causes of death in ESRD patients,

The American College of Cardiology Presented by Dr. Adnan Kastrati

ST T CHANGES Dr SRIKANTH KV MD DM ( CARDIOLOGY) SENIOR INTERVENTIONAL CARDIOLOGIST Specialist in Heart Failure Narayana Institute of Cardiac Sciences.

Patient populations by study group figure 10

PRISM-PLUS: Demographics of Patients With Diabetes

BVS Expand: First Results of Wide Clinical Applications

December 31st point prevalent counts by modality figure 3.1

End point Patients >75 y with renal insufficiency

Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

NOACs, AF, and PCI: What Do the Latest Data Suggest?

Table. Clinical Efficacy and Safety

Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

American College of Cardiology Presented by Dr. Stephan Windecker

Rounded incidence values (%) of renal and nonrenal events

Creatinine clearance in cases and controls

VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =

The US Renal Data System “Pie Chart of Death”

Chapter 8: Cardiovascular Disease in Patients with ESRD

Time point Difference in systolic BP (mm Hg) p

Risk of perioperative renal dysfunction with N-acetylcysteine or placebo in patients undergoing CABG surgery End point N-acetylcysteine Placebo Relative.

American Heart Association Presented by Dr. Julinda Mehilli

American College of Cardiology Presented by Dr. Michel R. Le May

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Heart Attack vs. Cardiac Arrest

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Cardiovascular complications in chronic kidney disease

Emilce Trucco et al. JACEP 2018;j.jacep

Cause of death Treatment-arm events, % (n=45 054)

Volume 80, Issue 6, Pages (September 2011)

Lynda Anne Szczech, Ira L. Lazar Kidney International

IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.

Exercise Testing in Right Bundle-Branch Block

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.

Charles A. Herzog Kidney International

NOBLE Trial design: Patients with unprotected left main disease were randomized to either PCI with a drug-eluting stent (DES) (88% biolimus) or CABG. They.

Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:

TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.

CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.

Figure 9.1.a Causes of death in ESRD patients,

Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.

Presentation transcript:

USRDS: Cause-specific mortality in ESRD patients undergoing revascularization Group/causes of death Mortality (%) at 1 year Mortality (%) at 3 years PTCA All-cause mortality 32.3 62.6 MI 7.8 15.4 Arrhythmic 9.9 23.7 Stent 28.9 58.1 6.3 11.0 9.5 21.5 CABG without IMG 37.1 61.8 5.3 10.7 11.6 22.7 CABG with IMG 27.6 51.6 3.6 7.1 8.5 17.5 Herzog C. American Heart Association Scientific Sessions 2004; Nov 7-10, 2004; New Orleans, LA.

USRDS/NRMI: Clinical characteristics and outcome in dialysis, nondialysis and nonrenal patients End point Dialysis patients Nondialysis renal failure Nonrenal patients p Chest pain on presentation (%) 42.8 44.0 67.8 <0.001 STEMI (ST elevation/left bundle branch block) (%) 25.4 26.5 39.8 Inhospital mortality (%) 21.3 21.9 10.7 Cardiac arrest (%) 12.0 8.7 5.5 Herzog C. American Heart Association Scientific Sessions 2004; Nov 7-10, 2004; New Orleans, LA.